Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource rightarrow Recombinant Protein rightarrow CTAG1A  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • Tenascin-C, TN-C ELISA Kit
 • Family With Sequence Similarity 3, Member B (FAM3B) ELISA Kit
 • CPT2 Antibody
 • CYCB1-1 Antibody
 • Prostate Specific Antigen (PSA) Antibody
 • DNMT2 ELISA Kit
 • Interferon alpha-beta receptor 2 (IFNAR2) Recombinant Protein
 • CD166 Antibody
 • 5-HT-3A Antibody
 • Alpha Fetoprotein (AFP) Protein
 • Galectin-13 (LGALS13) Recombinant Protein
 • CD79b Antibody
 • Insulin Receptor Antibody (AIRA) ELISA Kit
 • glutathione S-transferase pi 1 (GSTP1) ELISA Kit
 downarrow more ...
separator
separator
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

CTAG1A recombinant protein :: Cancer/testis antigen 1 Recombinant Protein

Scan QR to view Datasheet Catalog #    MBS957660
SDS-PAGE
Unit / Price
0.01 mg (E-Coli)  /  $150 +1 FREE 8GB USB
0.01 mg (Yeast)  /  $170 +1 FREE 8GB USB
0.05 mg (E-Coli)  /  $190 +1 FREE 8GB USB
0.05 mg (Yeast)  /  $220 +1 FREE 8GB USB
0.1 mg (E-Coli)  /  $285 +1 FREE 8GB USB
0.1 mg (Yeast)  /  $345 +1 FREE 8GB USB
0.2 mg (E-Coli)  /  $460 +1 FREE 8GB USB
0.2 mg (Yeast)  /  $545 +1 FREE 8GB USB
0.5 mg (E-Coli)  /  $750 +1 FREE 8GB USB
0.05 mg (Baculovirus)  /  $885 +1 FREE 8GB USB
0.5 mg (Yeast)  /  $900 +1 FREE 8GB USB
0.1 mg (Baculovirus)  /  $1,110 +1 FREE 8GB USB
0.05 mg (Mammalian-Cell)  /  $1,120 +1 FREE 8GB USB
1 mg (E-Coli)  /  $1,180 +1 FREE 8GB USB
1 mg (Yeast)  /  $1,410 +1 FREE 8GB USB
0.5 mg (Baculovirus)  /  $1,610 +2 FREE 8GB USB
0.1 mg (Mammalian-Cell)  /  $1,710 +2 FREE 8GB USB
1 mg (Baculovirus)  /  $2,150 +2 FREE 8GB USB
 
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

Cancer/testis antigen 1 (CTAG1A), Recombinant Protein

★Popular Item★
 Also Known As   

Recombinant Human Cancer/testis antigen 1 (CTAG1A)

 Product Synonym Names    Autoimmunogenic cancer/testis antigen NY-ESO-1; Cancer/testis antigen 6.1; CT6.1L antigen family member 2; LAGE-2
 Product Gene Name   

CTAG1A recombinant protein

[Similar Products]
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 MBS957660 COA    COA PDF
 Sequence Positions    1-180. Full length.
 Sequence    MQAEGRGTGG STGDADGPGG PGIPDGPGGN AGGPGEAGAT GGRGPRGAGA ARASGPGGGA PRGPHGGAAS GLNGCCRCGA RGPESRLLEF YLAMPFATPM EAELARRSLA QDAPPLPVPG VLLKEFTVSG NILTIRLTAA DHRQLQLSIS SCLQQLSLLM WITQCFLPVF LAQPPSGQRR
 OMIM    300156
 3D Structure    ModBase 3D Structure for P78358
Section Bar
 Host    E Coli or Yeast or Baculovirus or Mammalian Cell
Section Bar
 Purity/Purification    Greater than 90% as determined by SDS-PAGE. (lot specific)
 Form/Format    Liquid containing glycerol
 Tag Information    This protein contains an N-terminal tag and may also contain a C-terminal tag. Tag types are determined by various factors including tag-protein stability, please inquire for tag information.
 Sterility    Sterile filter available upon request.
 Endotoxin    Low endotoxin available upon request.
Section Bar
Section Bar
 Preparation and Storage    Store at -20 degree C, for extended storage, conserve at -20 degree C or -80 degree C.
 ISO Certification    Manufactured in an ISO 9001:2008 Certified Laboratory.
 Other Notes    Small volumes of CTAG1A recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar
 Product Categories/Family for CTAG1A recombinant protein    Cancer
Section Bar
 SDS-PAGE of CTAG1A recombinant protein    CTAG1A recombinant protein SDS-PAGE image
(Note: Representative image, actual molecular weight may vary depending on Tag type and expression host)
Table BarTOPTable Bar
NCBI/Uniprot data below describe general gene information for CTAG1A. It may not necessarily be applicable to this product.
 NCBI GI #    4503119
 NCBI GeneID    1485
 NCBI Accession #    NP_001318.1 [Other Products]
 NCBI GenBank Nucleotide #    NM_001327.2 [Other Products]
Section Bar
 UniProt Primary Accession #    P78358 [Other Products]
 UniProt Secondary Accession #    Q7LBY4; Q9NY13; A1L417; B7WNL9 [Other Products]
 UniProt Related Accession #    P78358 [Other Products]
 Molecular Weight    20kD
Table BarTOPTable Bar
 NCBI Official Full Name    cancer/testis antigen 1
 NCBI Official Synonym Full Names    cancer/testis antigen 1B
 NCBI Official Symbol    CTAG1B [Similar Products]
 NCBI Official Synonym Symbols   
CTAG; ESO1; CT6.1; CTAG1; LAGE-2; LAGE2B; NY-ESO-1
[Similar Products]
 NCBI Protein Information    cancer/testis antigen 1
 UniProt Protein Name    Cancer/testis antigen 1
 UniProt Synonym Protein Names   
Autoimmunogenic cancer/testis antigen NY-ESO-1; Cancer/testis antigen 6.1; CT6.1; L antigen family member 2; LAGE-2
 Protein Family    Cancer/testis antigen
 UniProt Gene Name    CTAG1A [Similar Products]
 UniProt Synonym Gene Names    CTAG; CTAG1; ESO1; LAGE2; LAGE2A; CT6.1; LAGE-2 [Similar Products]
 UniProt Entry Name    CTG1B_HUMAN
Section Bar
 NCBI Summary for CTAG1A    The protein encoded by this gene is an antigen that is overexpressed in many cancers but that is also expressed in normal testis. This gene is found in a duplicated region of the X-chromosome and therefore has a neighboring gene of identical sequence. [provided by RefSeq, Jan 2012]
Section Bar
 UniProt Comments for CTAG1A    CTAG1B: is an antigen that is overexpressed in many cancers but that is also expressed in normal testis. This gene is found in a duplicated region of the X-chromosome and therefore has a neighboring gene of identical sequence. [provided by RefSeq, Jan 2012]

Protein type: Cancer Testis Antigen (CTA)

Chromosomal Location of Human Ortholog: Xq28

Cellular Component: cytoplasm

Molecular Function: protein binding
Table BarTOPTable Bar
 

Product References and Citations for CTAG1A recombinant protein

   A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.Chen Y.-T., Scanlan M.J., Sahin U., Tuereci O., Gure A.O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L.J.Proc. Natl. Acad. Sci. U.S.A. 94:1914-1918(1997) LAGE-1, a new gene with tumor specificity.Lethe B.G., Lucas S., Michaux L., De Smet C., Godelaine D., Serrano A., De Plaen E., Boon T.3.0.CO;2-1>Int. J. Cancer 76:903-908(1998) A breast and melanoma-shared tumor antigen T cell responses to antigenic peptides translated from different open reading frames.Wang R.-F., Johnston S.L., Zeng G., Topalian S.L., Schwartzentruber D.J., Rosenberg S.A.J. Immunol. 161:3598-3606(1998) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.De Smet C., Lurquin C., Lethe B.G., Martelange V., Boon T.Mol. Cell. Biol. 19:7327-7335(1999) Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes.Aradhya S., Bardaro T., Galgoczy P., Yamagata T., Esposito T., Patlan H., Ciccodicola A., Kenwrick S., Platzer M., D'Urso M., Nelson D.L.Hum. Mol. Genet. 10:2557-2567(2001) The DNA sequence of the human X chromosome.Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S., Rogers J., Bentley D.R.Nature 434:325-337(2005)
Section Bar
 Research Articles on CTAG1A    1. NY-ESO-1 expression in melanoma was associated with tumor progression, including increased tumor thickness, and with reduced tumor infiltrating lymphocytes.
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with CTAG1A recombinant proteinDiseases associated with CTAG1A recombinant protein
 Reference Product  PubMed Publications
 MAGEA4 recombinant protein  >34 publications with CTAG1A and MAGEA4
 MAGEC1 recombinant protein  >15 publications with CTAG1A and MAGEC1
 HLA-DRB1 recombinant protein  >9 publications with CTAG1A and HLA-DRB1
 Disease Name  Pubmed Publications
 Endocrine System Diseases Antibodies  >46 publications with CTAG1A and Endocrine System Diseases
 Endocrine Gland Neoplasms Antibodies  >44 publications with CTAG1A and Endocrine Gland Neoplasms
 Carcinoma, Non-Small-Cell Lung Antibodies  >20 publications with CTAG1A and Carcinoma, Non-Small-Cell Lung
 Leukemia, Myeloid Antibodies  >4 publications with CTAG1A and Leukemia, Myeloid
 Hematologic Neoplasms Antibodies  >4 publications with CTAG1A and Hematologic Neoplasms
 Leukemia, Myeloid, Acute Antibodies  >4 publications with CTAG1A and Leukemia, Myeloid, Acute
 Rhabdomyosarcoma Antibodies  >4 publications with CTAG1A and Rhabdomyosarcoma
 Uveal Neoplasms Antibodies  >2 publications with CTAG1A and Uveal Neoplasms
 Acute Disease Antibodies  >1 publications with CTAG1A and Acute Disease
 Myelodysplastic Syndromes Antibodies  >1 publications with CTAG1A and Myelodysplastic Syndromes
Organs/Tissues associated with CTAG1A recombinant protein
 Organ/Tissue Name  Pubmed Publications
 Testis Antibodies  >245 publications with CTAG1A and Testis
 Bone Antibodies  >12 publications with CTAG1A and Bone
 Placenta Antibodies  >6 publications with CTAG1A and Placenta
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions